Skip to content
PeptideRank

Price report · Q4 2026

Peptide & GLP-1 Telehealth Price Report, Q4 2026

  • We read 594 listings from 204 telehealth sellers across 7 compounds, each on the seller's own site.
  • Compounded tirzepatide: a median of $258 a month ($84–$499, 153 sellers).
  • Compounded semaglutide: a median of $198 a month ($49–$399, 177 sellers).
  • 247 of 589 advertised prices (42%) carry a condition the number does not state.
  • 56 of 204 sellers (27%) say whether a 503A or 503B pharmacy makes the drug.

Prices read between August 2026 and October 2026. Cite as PeptideRank, Q4 2026 Price Report.

sellers, 594 listings across 7 compounds
204
sellers, 594 listings across 7 compounds
median monthly price, compounded tirzepatide
$258
median monthly price, compounded tirzepatide
of advertised prices carry a condition the number omits
42%
of advertised prices carry a condition the number omits
of sellers state a 503A or 503B pharmacy category
27%
of sellers state a 503A or 503B pharmacy category

What does each compound cost per month?

The lowest monthly price each seller advertises, including any fee you must pay to buy at all. The dot is the median; the bar runs from the lowest to the highest seller.

  • Tirzepatide153 sellers
    $258
  • Semaglutide177 sellers
    $198
  • Sermorelin79 sellers
    $199
  • NAD+68 sellers
    $168
  • Glutathione38 sellers
    $142
  • PT-1419 sellers
    $199
  • GHK-Cu18 sellers
    $147
Median Lowest to highestFull figures in the table below.
Monthly price by compound, Q4 2026
CompoundLowestMedianHighest
Tirzepatide153 sellers$84$258$499
Semaglutide177 sellers$49$198$399
Sermorelin79 sellers$99$199$349
NAD+68 sellers$84$168$271
Glutathione38 sellers$80$142$249
PT-1419 sellers$135$199$299
GHK-Cu18 sellers$76$147$249

“Sellers” counts those with a monthly price. The rest of each list prices per vial, give no billing period, or publish no price, so there is no month to quote. Every row, with its date, is on the pricing index.

How often is the advertised price what you actually pay?

342 of 589 advertised prices (58%) are a plain monthly rate. The rest are a “from” figure, a first month that rises, a monthly rate that needs months paid up front, or another condition.

  • A plain monthly rate342 · 58%
  • Only a "from" price90 · 15%
  • A monthly rate you cannot pay monthly54 · 9%
  • A first-month rate that rises43 · 7%
  • No price published23 · 4%
  • A number with no billing period20 · 3%
  • A price plus a mandatory fee8 · 1%
  • A dose-tier range5 · 1%
  • Priced per vial, not per month4 · 1%
Each price counted once, under the most serious condition that applies. 589 prices.

What each condition means, seller by seller: the price transparency report.

How many sellers say which kind of pharmacy makes the drug?

56 of 204 sellers state a 503A or 503B category on their own site. 148 do not, even though every one of them was read.

  • Not disclosed147 · 72%
  • 503A pharmacy51 · 25%
  • 503B facility3 · 1%
  • 503A + 503B network2 · 1%
  • Unnamed network1 · <1%
What each seller states about the pharmacy category. 204 sellers.

Seller by seller, with the page we read: the pharmacy transparency report.

How this report is built

  • Who is in it. Every seller listed for any of the 7 compounds on PeptideRank: 594 listings from 204 sellers.
  • Where prices come from. The seller's own public website, read on the date stored with each price, never an affiliate landing page.
  • Monthly price. The lowest monthly price a seller advertises for that compound, plus any required membership fee. A 4-week or 12-week price is converted to a month. First-month promotions are not used.
  • What is left out of the medians. Per-vial prices, prices with no billing period, and sellers that publish no price. They are counted, not estimated.
  • Price conditions and pharmacy category. The same counts as the price and pharmacy transparency reports. A seller is counted as stating a category only when its own page states it.
  • How it updates. Every figure is recomputed from the price record each time the site is published, and the report is reissued each quarter. Rules for checking prices are in our editorial policy.

Citing this report

Free to quote with attribution to PeptideRank and a link to this page. The figures are point-in-time: cite them as of October 2026. The row-level data is downloadable as a CSV.

Nothing on this page is medical advice. Compounded medications are not FDA-approved. Sellers change prices without notice, so check the current price on the seller's site before you buy.